SoftBank-backed Neumora bags $2.51 billion valuation in lackluster debut
Shares of Neumora Therapeutics , which is backed by Amgen and Japan's SoftBank , fell in their market debut on ...
Tag: Neumora Therapeutics debut
Shares of Neumora Therapeutics , which is backed by Amgen and Japan's SoftBank , fell in their market debut on ...
